Petpharmbio operates dual cyclotrons—the IBA CYCLONE® IKON and Sumitomo HM-12S—backed by 7 multi-isotope automated synthesis modules and fully enclosed aseptic dispensing systems. Together, they form the most robust manufacturing infrastructure among Taiwan's private radiopharmaceutical facilities.








The flagship model from Belgium's IBA (Ion Beam Applications), engineered specifically for high-efficiency, large-scale radioisotope production. Petpharmbio finalized the procurement contract in 2025, becoming the first private radiopharmaceutical company in Taiwan to introduce this next-generation accelerator. This acquisition significantly boosts F-18 production stability, laying a solid foundation for drug supply over the next decade.
Superior isotope output
Real-time remote control
Imported from Japan's Sumitomo Heavy Industries, this precision cyclotron is renowned for its operational stability. Paired with the IBA system to form a dual-accelerator redundancy network, it can seamlessly assume full production during routine maintenance of either unit, fulfilling our commitment to zero supply interruption.
Japanese import quality
Dual-system redundancy


Fully automated, closed-loop synthesis modules execute complete radiolabeling protocols according to programmed sequences. Operating under negative-pressure isolation, the system eliminates external contamination and supports batch synthesis for multiple isotopes including F-18, Ga-68, and I-131.

Operating within a Class A cleanroom environment, this system dispenses radiopharmaceuticals into single patient doses according to hospital orders. It automatically calculates decay correction factors to ensure dosage accuracy complies with pharmacopeial standards.